公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2015 | MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma | Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; HONG-CHIANG CHANG ; Hsieh J.-T.; Wu J.-T.; CHIH-KANG CHIANG ; WEI-CHOU LIN ; YU-CHIEH TSAI ; Chou C.-T.; Hsu C.-H.; YEONG-SHIAU PU ; Shi C.-S.; KUO-HOW HUANG | Scientific Reports | 35 | 35 | |
2015 | MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies | Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; WEI-CHOU LIN ; YU-CHIEH TSAI ; HONG-CHIANG CHANG ; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; YEONG-SHIAU PU ; KUO-HOW HUANG | Cancer Letters | 48 | 51 | |
2007 | Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma | CHIA-CHI LIN ; KUN-HUEI YEH ; CHIH-HSIN YANG ; CHIUN HSU ; YU-CHIEH TSAI ; Hsu W.-L.; ANN-LII CHENG ; CHIH-HUNG HSU | Anti-Cancer Drugs | 10 | 8 | |
2023 | Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer | Chi, Kim N; Rathkopf, Dana; Smith, Matthew R; Efstathiou, Eleni; Attard, Gerhardt; Olmos, David; Lee, Ji Youl; Small, Eric J; Pereira de Santana Gomes, Andrea J; Roubaud, Guilhem; Saad, Marniza; Zurawski, Bogdan; Sakalo, Valerii; Mason, Gary E; Francis, Peter; Wang, George; Wu, Daphne; Diorio, Brooke; Lopez-Gitlitz, Angela; Sandhu, Shahneen; YU-CHIEH TSAI | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 58 | 42 | |
2019 | Nuclear Factor-κB Overexpression is Correlated with Poor Outcomes after Multimodality Bladder-Preserving Therapy in Patients with Muscle-Invasive Bladder Cancer | CHIANG, YUN ; Wang, Chung-Chieh; YU-CHIEH TSAI ; CHAO-YUAN HUANG ; YEONG-SHIAU PU ; CHIA-CHI LIN ; CHIA-HSIEN CHENG | Journal of clinical medicine | 8 | 7 | |
2014 | Osteoblast-derived WISP-1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126 | HUAI-CHING TAI ; Chang A.-C.; HONG-JENG YU ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; Lai Y.-W.; Sun H.-L.; Tang C.-H.; Wang S.-W. | Oncotarget | 51 | | |
2002 | Osteonecrosis of the femoral head in a human immunodeficiency virus type 1-infected patient with lipodystrophy | YU-CHIEH TSAI ; CHEN-HUA LIU ; Liao C.-H.; Chen M.-Y.; CHIEN-CHING HUNG | Journal of the Formosan Medical Association | 4 | 5 | |
2017 | Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population | Lin Y.-C.; Hour T.-C.; YU-CHIEH TSAI ; Huang S.-P.; Wu W.-J.; CHUNG-HSIN CHEN ; YEONG-SHIAU PU ; Chung S.-D.; CHAO-YUAN HUANG | Urologic Oncology: Seminars and Original Investigations | 11 | 10 | |
2021 | Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection | YU-CHIEH TSAI ; Sou F.-M.; Liu Y.-W.; Wu Y.-J.; Yong C.-C.; Chen D.-W.; Huang P.-Y.; Cho W.-R.; Chuang C.-H.; Hsiao C.-C.; Hu T.-H.; Tsai M.-C. | BMC Gastroenterology | 6 | 7 | |
2007 | Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; KUO-HOW HUANG ; ANN-LII CHENG ; YEONG-SHIAU PU | Urology | 24 | 21 | |
2019 | Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma | JHE-CYUAN GUO ; YU-CHIEH TSAI ; YEONG-SHIAU PU | Urological Science | 1 | 1 | |
2005 | Response of refractory osteosarcoma to thalidomide and celecoxib | YU-CHIEH TSAI ; CHEN-TU WU ; RUEY-LONG HONG | Lancet Oncology | 15 | 14 | |
2011 | Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma | Feng-Ming Hsu ; JANG-MING LEE ; PEI-MING HUANG ; CHIA-CHI LIN ; CHIH-HUNG HSU ; YU-CHIEH TSAI ; Lee Y.-C.; CHIA-HSIEN CHENG | International Journal of Radiation Oncology Biology Physics | 38 | 36 | |
2022 | The risk of subsequent malignancies in patients with renal cell carcinoma: A nationwide, population-based study | Lu, Yu Cheng; YU-CHIEH TSAI ; PO-MING CHOW ; Weng, Wen Ching; Huang, Wei Yi; SHIH-CHIEH CHUEH ; KAO-LANG LIU ; KUO-HOW HUANG | Urological Science | 0 | 0 | |
2017 | A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement | YUN CHIANG ; CHIA-HSIEN CHENG ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; Chia-Chi Lin ; CHIH-HUNG HSU ; ANN-LII CHENG ; YEONG-SHIAU PU | Journal of the Formosan Medical Association | 7 | 6 | |
2023 | Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling | YU-CHIEH TSAI ; Wang, Tzu-Yin; Hsu, Chia-Lang; WEI-CHOU LIN ; Chen, Jyun-Yu; Li, Jia-Hua; YEONG-SHIAU PU ; ANN-LII CHENG ; CHIA-HSIEN CHENG ; SHENG-FANG SU | British journal of cancer | 4 | 4 | |
2012 | The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells | Xu D.; Lin T.-H.; Zhang C.; YU-CHIEH TSAI ; Li S.; Zhang J.; Yin M.; Yeh S.; Chang C. | Prostate | 19 | 18 | |
2021 | Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma | Yang S.-Y.; Wang C.-C.; Chen K.-D.; Liu Y.-W.; Lin C.-C.; Chuang C.-H.; YU-CHIEH TSAI ; Yao C.-C.; Yen Y.-H.; Hsiao C.-C.; Hu T.-H.; Tsai M.-C. | BMC Cancer | 12 | 11 | |
2007 | Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer | CHUNG-HSIN CHEN ; CHIA-TUNG SHUN ; KUO-HOW HUANG ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; HONG-JENG YU ; YEONG-SHIAU PU | BJU International | 101 | 87 | |
2015 | Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cells | YU-CHIEH TSAI ; Ho P.-Y.; KAI-YUAN TZEN ; Tuan T.-F.; Liu W.-L.; ANN-LII CHENG ; YEONG-SHIAU PU ; CHIA-HSIEN CHENG | Molecular Cancer Therapeutics | 25 | 26 | |